Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus
- PMID: 231433
Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus
Abstract
Four tests for antibody to varicella-zoster (V-Z) virus were compared; these were tests of complement fixation (CF), neutralization (NT), fluorescent antibody to membrane antigen (FAMA) and immune adherence hemagglutination (IAHA). Fifty-two sera from patients with varicella and zoster and from recipients of live varicella vaccine were examined by the 4 tests. The CF test was least sensitive, but the antibody titers by the NT, FAMA and IAHA tests were roughly comparable. The IAHA test was the simplest and fastest to perform, and appeared suitable for routine serological assay to V-Z virus. The correlation between the IAHA antibody titer and susceptibility of individuals to clinical varicella was investigated retrospectively using sera obtained during 2 outbreaks of varicella in an institution for children, where all the unvaccinated children had developed varicella symptoms. Most of the 25 pre-exposure sera from unvaccinated children examined by the IAHA test had tiers of less than 1:2. In contrast, all the 23 sera from vaccinated children who did not develop varicella had detectable antibody titers of 1:2 to 1:64. These results indicate that the IAHA titer reflects the susceptibility or resistance of individuals to clinical varicella.
Similar articles
-
Detection of varicella-zoster antibody by immune adherence hemagglutination test.Southeast Asian J Trop Med Public Health. 1984 Sep;15(3):342-7. Southeast Asian J Trop Med Public Health. 1984. PMID: 6098021
-
Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test.Pediatrics. 1975 Dec;56(6):1005-8. Pediatrics. 1975. PMID: 172853
-
Serum antibody levels as risk factors in the dissemination of herpes zoster.Arch Intern Med. 1979 Dec;139(12):1341-5. Arch Intern Med. 1979. PMID: 229783
-
Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.J Infect Dis. 2008 Mar 1;197 Suppl 2:S147-51. doi: 10.1086/529448. J Infect Dis. 2008. PMID: 18419389 Review.
-
Assays for antibodies to varicella-zoster virus.Infect Dis Clin North Am. 1996 Sep;10(3):507-27. doi: 10.1016/s0891-5520(05)70311-1. Infect Dis Clin North Am. 1996. PMID: 8856350 Review.
Cited by
-
Virus replication and localization of varicella-zoster virus antigens in human embryonic fibroblast cells infected with cell-free virus.Infect Immun. 1980 May;28(2):536-41. doi: 10.1128/iai.28.2.536-541.1980. Infect Immun. 1980. PMID: 6249744 Free PMC article.
-
Immune response after exposure to varicella zoster virus: characterization of virus-specific antibodies and their corresponding antigens.Infect Immun. 1981 Jan;31(1):436-44. doi: 10.1128/iai.31.1.436-444.1981. Infect Immun. 1981. PMID: 6260665 Free PMC article.
-
Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.J Clin Microbiol. 1987 Nov;25(11):2193-6. doi: 10.1128/jcm.25.11.2193-2196.1987. J Clin Microbiol. 1987. PMID: 2826535 Free PMC article.
-
Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus.J Clin Microbiol. 1982 Nov;16(5):878-84. doi: 10.1128/jcm.16.5.878-884.1982. J Clin Microbiol. 1982. PMID: 6759530 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials